FAC · Factorial Energy Inc.

Current Thesis

Factorial Energy's solid-state battery commercialization story supports a tentative recovery case: a weekly close at or above $8 before a weekly close below $4.24 would establish the defined price outcome. The upper reference is Oppenheimer's 2026-08-25 analyst target; the lower reference is the market's reported 2026-07-13 low. These are research conditions, not forecasts issued by those sources. Analyst history, historical low.

Since the 2026-08-30 note, the measured improvement is in price and momentum. The supplied adjusted series records a $5.31 close on 2026-09-11, compared with the previously published $4.91 close on 2026-08-28; the 14-day relative strength index (RSI) reached 60.2. Nevertheless, the September observation remains 75.8% below the adjusted 52-week high, with a three-month price decline of 65.4%.

For the original debut-driven repricing, the narrative is dead — the 2026-09-11 drawdown still supports the failed-structure assessment published on 2026-08-30. That is an inference about market reception, not a finding that the technology has failed. The recovery case has low conviction because the improved momentum has not yet reached the published $8 outcome threshold.

Bullish and bearish views on Factorial Energy Inc.

The model's bull view on Factorial Energy Inc. (FAC), in brief: Cash supports continued development. Factorial reported approximately $112.8 million in cash and equivalents at 2026-06-30, alongside approximately $40 million of adjusted operating expenses and $13 million of capital expenditure guidance for 2026. August 11 shareholder letter.… The bear view: Revenue remains a future milestone. Management's 2026-08-11 letter placed first commercial revenue in 2027. A revision beyond that year would break the commercialization timetable underpinning the recovery case. Shareholder letter. Analyst support has not broadened. Benzinga's… Both cases follow in full.

Bull Case

• Cash supports continued development. Factorial reported approximately $112.8 million in cash and equivalents at 2026-06-30, alongside approximately $40 million of adjusted operating expenses and $13 million of capital expenditure guidance for 2026. August 11 shareholder letter.

• Commercial deployment has an order. The 2026-08-11 letter confirmed a July drone-battery order, providing evidence beyond testing; it also disclosed that fulfillment may include third-party cells. Shareholder letter.

• Attention returned during September. Benzinga included FAC in its 2026-09-08 morning gainers report. That establishes renewed coverage, although a single article cannot establish expanding participation. September 8 report.

Bear Case

• Revenue remains a future milestone. Management's 2026-08-11 letter placed first commercial revenue in 2027. A revision beyond that year would break the commercialization timetable underpinning the recovery case. Shareholder letter.

• Analyst support has not broadened. Benzinga's analyst history checked on 2026-09-13 still lists Oppenheimer's August 25 initiation at $8 and Cantor Fitzgerald's August 12 reiteration at $18 as its latest target-bearing actions. This source supplies no subsequent target increase. Analyst history.

• The drawdown remains substantial. The supplied 2026-09-11 adjusted series records a three-month decline of 65.4%. The higher latest close alone does not establish a durable reversal.

Setup & Price Structure

The 2026-09-11 adjusted close of $5.31 is the reference for this assessment. The reported July 13 low of $4.24 supplies the thesis-break condition; a weekly close below $4.24 invalidates the recovery case. A weekly close at or above Oppenheimer's August 25 target of $8 defines the successful price outcome, without treating an analyst target as demonstrated chart resistance. Historical low, Oppenheimer target.

The positioning evidence is limited to observable attention: the August 25 initiation and September 8 gainers coverage. That sample is too small to support a crowding claim. The September 11 snapshot supplies neither moving-average levels nor volume history, so distance above a rising average and accumulation cannot be established.

Catalyst Calendar (next 30 days)

For 2026-09-13 through 2026-10-13, no confirmed company catalyst was identified in Factorial's investor-relations material checked on September 13. The latest displayed results release remained dated August 11; the earlier estimated November earnings date is unconfirmed and is not treated as scheduled. Investor relations.

• 2026-12-31 — Technical milestone deadline. Beyond this window, management's August 11 letter targeted approximately 450 watt-hours per kilogram for drone programs by year-end. Failure to demonstrate that milestone by the deadline would invalidate the stated technical timetable. Shareholder letter.

What Would Change Our Mind

Loss of the July 13 low would end the recovery case: a weekly close below $4.24 is the explicit price invalidation. Conversely, a weekly close at or above the $8 outcome threshold before that breach would overturn the assessment that the rebound remains unconfirmed. These conditions use the historical market low and Oppenheimer's August 25 target already identified above.

Commercial validation requires product attribution. Because the August 11 letter permits third-party cells in the drone order, shipment confirmation alone would not establish deployment of Factorial's proprietary cells. Shareholder letter.

Correlation Notes

FAC is assessed as a single-name setup in this September 13 update. Its inclusion alongside biotechnology and Quantum computing names in Benzinga's September 8 gainers article is an editorial grouping, not evidence of common return drivers. No matched peer-return series is supplied, so a battery-sector correlation or a broader speculative-market relationship cannot be measured. September 8 coverage.